NCT05682989 Efficacy/Safety of Urogynecology Synthetic Mesh Surgery
| NCT ID | NCT05682989 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Mackay Medical College |
| Condition | Pelvic Organ Prolapse |
| Study Type | OBSERVATIONAL |
| Enrollment | 150 participants |
| Start Date | 2022-08-01 |
| Primary Completion | 2023-08-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 150 participants in total. It began in 2022-08-01 with a primary completion date of 2023-08-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This is a retrospective cohort study, aiming at analyzing the efficacy and safety of mesh surgery in pelvic organ prolapse. The synthetic mesh for pelvic organ prolapse include transvaginal mesh or laparotomy, laparoscope, or robotic-assisted laparoscopic sacrocolpopexy with mesh augmentation. The investigators would like to evaluate the efficacy and safety, such as recurrence rates and complication rates for women who underwent urogynecology mesh surgery.
Eligibility Criteria
Inclusion Criteria: * Pelvic organ prolapse patients with objective / subjective voiding dysfunctions * Underwent surgery for symptomatic POP ≥ stage II (POP-Q system) Exclusion Criteria: * Patients with a history of pelvic radiation. * Patients with a history of vesico-/recto-/urethra-vaginal fistula * Patients unable to be followed up.
Contact & Investigator
Hui-Hsuan Lau, M.D.
STUDY CHAIR
Department of Ear, Nose, and Throat, MacKay Memorial Hospital, Taipei, Taiwan
Frequently Asked Questions
Who can join the NCT05682989 clinical trial?
This trial is open to female participants only, aged 30 Years or older, up to 100 Years, studying Pelvic Organ Prolapse. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT05682989 currently recruiting?
Yes, NCT05682989 is actively recruiting participants. Contact the research team at huihsuan1220@gmail.com for enrollment information.
Where is the NCT05682989 trial being conducted?
This trial is being conducted at New Taipei City, Taiwan.
Who is sponsoring the NCT05682989 clinical trial?
NCT05682989 is sponsored by Mackay Medical College. The principal investigator is Hui-Hsuan Lau, M.D. at Department of Ear, Nose, and Throat, MacKay Memorial Hospital, Taipei, Taiwan. The trial plans to enroll 150 participants.